Carlo Arcara

521 total citations
11 papers, 416 citations indexed

About

Carlo Arcara is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Carlo Arcara has authored 11 papers receiving a total of 416 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 3 papers in Pulmonary and Respiratory Medicine and 2 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Carlo Arcara's work include Bone health and treatments (3 papers), Pain Management and Opioid Use (2 papers) and Pediatric Pain Management Techniques (2 papers). Carlo Arcara is often cited by papers focused on Bone health and treatments (3 papers), Pain Management and Opioid Use (2 papers) and Pediatric Pain Management Techniques (2 papers). Carlo Arcara collaborates with scholars based in Italy, Argentina and United States. Carlo Arcara's co-authors include Nicola Gebbia, Fabio Fulfaro, Carla Montesano, Guido Sireci, Fabrizio Poccia, Maria Rosaria Valerio, Caterina Di Sano, Alfredo Salerno, Francesco Dieli and Serena Meraviglia and has published in prestigious journals such as Blood, Journal of Pain and Symptom Management and Clinical Journal of Pain.

In The Last Decade

Carlo Arcara

11 papers receiving 408 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carlo Arcara Italy 7 200 134 83 67 59 11 416
Huang‐Chou Chang Taiwan 11 99 0.5× 46 0.3× 169 2.0× 68 1.0× 70 1.2× 19 471
Wei Zeng China 11 81 0.4× 35 0.3× 122 1.5× 14 0.2× 42 0.7× 36 351
Thorsten Dohrmann Germany 10 135 0.7× 47 0.4× 69 0.8× 61 0.9× 29 0.5× 23 304
Yuan Han China 10 32 0.2× 47 0.4× 140 1.7× 26 0.4× 69 1.2× 17 362
Carmen Mota Reyes Germany 8 299 1.5× 79 0.6× 26 0.3× 9 0.1× 77 1.3× 18 374
Xian Su China 12 88 0.4× 153 1.1× 189 2.3× 38 0.6× 69 1.2× 33 501
Ruby Kuang United States 9 68 0.3× 131 1.0× 91 1.1× 5 0.1× 51 0.9× 14 345
Hikaru Nakashima Japan 11 121 0.6× 41 0.3× 160 1.9× 7 0.1× 93 1.6× 18 383
Siming Ai China 11 44 0.2× 31 0.2× 67 0.8× 9 0.1× 25 0.4× 25 225

Countries citing papers authored by Carlo Arcara

Since Specialization
Citations

This map shows the geographic impact of Carlo Arcara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlo Arcara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlo Arcara more than expected).

Fields of papers citing papers by Carlo Arcara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carlo Arcara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlo Arcara. The network helps show where Carlo Arcara may publish in the future.

Co-authorship network of co-authors of Carlo Arcara

This figure shows the co-authorship network connecting the top 25 collaborators of Carlo Arcara. A scholar is included among the top collaborators of Carlo Arcara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carlo Arcara. Carlo Arcara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
2.
Apice, Gaetano, Massimo Di Maïo, Giovanni Grignani, et al.. (2016). Confirmed Activity and Tolerability of Weekly Paclitaxel in the Treatment of Advanced Angiosarcoma. Sarcoma. 2016. 1–7. 14 indexed citations
3.
Gebbia, Vittorio, Evaristo Maiello, Francesco Giuliani, et al.. (2010). Irinotecan Plus Bolus/Infusional 5-Fluorouracil and Leucovorin in Patients With Pretreated Advanced Pancreatic Carcinoma. American Journal of Clinical Oncology. 33(5). 461–464. 27 indexed citations
4.
Mercadante, Sebastiano, Walter Tirelli, Fabrizio David, et al.. (2010). Morphine Versus Oxycodone in Pancreatic Cancer Pain. Clinical Journal of Pain. 26(9). 794–797. 38 indexed citations
5.
Mercadante, Sebastiano, Vittorina Zagonel, Enrico Breda, et al.. (2010). Breakthrough Pain in Oncology: A Longitudinal Study. Journal of Pain and Symptom Management. 40(2). 183–190. 40 indexed citations
6.
Maiello, Evaristo, Vittorio Gebbia, Luigi Manzione, et al.. (2008). Clinical results of EGFR-targeted therapies in advanced colorectal cancer. European Journal of Cancer Supplements. 6(14). 64–69. 1 indexed citations
7.
Incorvaia, Lorena, Giuseppe Badalamenti, GiovamBattista Rini, et al.. (2007). MMP-2, MMP-9 and activin A blood levels in patients with breast cancer or prostate cancer metastatic to the bone.. PubMed. 27(3B). 1519–25. 67 indexed citations
8.
Leto, Gaetano, Giuseppe Badalamenti, Carlo Arcara, et al.. (2006). Effects of zoledronic acid on proteinase plasma levels in patients with bone metastases.. PubMed. 26(1A). 23–6. 15 indexed citations
9.
Siragusa, Sergio, Alessandra Malato, Raffaela Anastasio, et al.. (2005). The Persistance of Residual Vein Thrombosis, after an Episode of Deep Vein Thrombosis, and the Risk of New Overt Cancer and Cardiovascular Disease.. Blood. 106(11). 262–262. 1 indexed citations
10.
Siragusa, Sergio, Raffaela Anastasio, Antonino Giarratano, et al.. (2004). Managing cancer patients with acute venous thromboembolism: exploring safe alternatives to hospitalisation.. PubMed. 26(3). 192–5. 3 indexed citations
11.
Dieli, Francesco, Nicola Gebbia, Fabrizio Poccia, et al.. (2003). Induction of γδ T-lymphocyte effector functions by bisphosphonate zoledronic acid in cancer patients in vivo. Blood. 102(6). 2310–2311. 208 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026